As previously discussed (see Section 3.1), zotiraciclib decreased transcription of the anti-apoptotic proteins MCL-1 and Survivin in glioblastoma cells, resulting in apoptosis [35]. This evidence concerns the gene BIRC5 and glioblastoma.